Prognostic factors in breast cancer patients following neoadjuvant chemotherapy

被引：0
|
作者：
Kim, JR [1 ]
Chang, ES [1 ]
机构：
[1] Chungnam Natl Univ, Dept Surg, Taejon 305764, South Korea
来源：
BIOMEDICINE & PHARMACOTHERAPY | 2005年 / 59卷
关键词：
breast cancer; neoadjuvant chemotherapy; axillary lymph node;
D O I：
10.1016/S0753-3322(05)80093-9
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
引用
收藏
页码：S395 / S396
页数：2
相关论文
共 50 条
  • [31] Factors predictive of outcome in patients with breast cancer refractory to neoadjuvant chemotherapy
    Buchholz, TA
    Hill, BS
    Tucker, SL
    Frye, DK
    Kuerer, HM
    Buzdar, AU
    McNeese, MD
    Singletary, SE
    Ueno, NT
    Pusztai, L
    Valero, V
    Hortobagyi, GN
    CANCER JOURNAL, 2001, 7 (05): : 413 - 420
  • [32] Predictive factors of pathological response to neoadjuvant chemotherapy in patients with breast cancer
    Ryspayeva, Dinara
    Lyashenko, Andrey
    Dosenko, Irina
    Kostryba, Oleksey
    Koshyk, Olena
    Krotevych, Mykhailo
    Smolanka, Ivan
    JOURNAL OF BUON, 2020, 25 (01): : 168 - 175
  • [33] Factors Affecting the Complete Response in Breast and Axillary Regions Following Neoadjuvant Chemotherapy for Breast Cancer
    Ozgul, Halit
    Cakir, Remzi Can
    Celik, Omer
    Yildiz, Turan Can
    Aydemir, Erhan
    Hark, Betul Dagoglu
    Lale, Azmi
    HASEKI TIP BULTENI-MEDICAL BULLETIN OF HASEKI, 2024, 62 (04): : 216 - 222
  • [34] Clinical Outcome and Prognostic Factors in Iranian Breast Cancer Patients After Neoadjuvant Chemotherapy: A Comparative Matched Study
    Kashi, Amir Shahram Yousefi
    Montazeri, Rezvan
    Rakhsha, Afshin
    INTERNATIONAL JOURNAL OF CANCER MANAGEMENT, 2018, 11 (05)
  • [35] The prognostic factors of the HER2-positive breast cancer patients with residual tumor after neoadjuvant chemotherapy
    Tokunaga, Eriko
    Koi, Yumiko
    Ijichi, Hideki
    Koga, Chinami
    Tajiri, Wakako
    Nakamura, Yoshiaki
    Taguchi, Kenichi
    Okamoto, Masahiro
    CANCER SCIENCE, 2022, 113 : 1166 - 1166
  • [36] Prognostic Factors for Locoregional Recurrence in HER-2 Overexpressing Breast Cancer Patients Treated with Neoadjuvant Chemotherapy
    Arsenault, D. M.
    Hurley, J.
    Reis, I.
    Zhao, W.
    Takita, C.
    Gomez, C.
    Jorda, M.
    Cioffi-Lavina, M.
    Villasboas, J. C.
    Wright, J. L.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2011, 81 (02): : S225 - S225
  • [37] Prognostic Factors of Survival in Pathologic Incomplete Response Patients with Locally Advanced Breast Cancer After Neoadjuvant Chemotherapy
    Ou Huang
    Min Jiang
    Xiao-song Chen
    Jia-yi Wu
    Wei-guo Chen
    Ya-fei Li
    Kun-wei Shen
    Cell Biochemistry and Biophysics, 2015, 71 : 1181 - 1190
  • [38] Prognostic Factors of Survival in Pathologic Incomplete Response Patients with Locally Advanced Breast Cancer After Neoadjuvant Chemotherapy
    Huang, Ou
    Jiang, Min
    Chen, Xiao-Song
    Wu, Jia-Yi
    Chen, Wei-Guo
    Li, Ya-Fei
    Shen, Kun-Wei
    CELL BIOCHEMISTRY AND BIOPHYSICS, 2015, 71 (02) : 1181 - 1190
  • [39] Prognostic factors for patients with invasive ductal carcinoma of the breast who received neoadjuvant chemotherapy
    Tamura, N.
    BREAST, 2009, 18 : S33 - S33
  • [40] Prognostic factors for patients with invasive ductal carcinoma of the breast who received neoadjuvant chemotherapy
    Tamura, N.
    Tamura, N.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
12345